FdaApplication
BLA 761440
Identifiers
- fda_app_no: BLA761440
Properties
| Property | Value |
|---|---|
| applicant_name | GlaxoSmithKline LLC |
| application_type | BLA |
| approval_date | 2025-10-23 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BLENREP | BELANTAMAB MAFODOTIN-BLMF | 70MG | For Injection |
1 product